Johns Hopkins Medicine: Computational Tool Developed to Predict Immunotherapy Outcomes for Patients With Metastatic Breast Cancer
October 30, 2024
October 30, 2024
BALTIMORE, Maryland, Oct. 30 (TNSres) -- Johns Hopkins Medicine issued the following news release:
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy. The work by computational scientists and clinicians was published Oct. 28 in the Proceedings of the National Academy of Scie . . .
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy. The work by computational scientists and clinicians was published Oct. 28 in the Proceedings of the National Academy of Scie . . .